Recommended Global Pharmaceutical Sciences Conferences
Future Pharma 2019
Future Pharma 2019 cordially invites participants from all over the world to attend “12th World Congress on Future Pharma”, scheduled during January 28-29, 2019 at Paris, France, and mainly focused on the theme “Pioneering the Development of Future Pharma”.
The event offers a best platform with its well organized scientific program to the audience which includes interactive panel discussions, keynote lectures, plenary talks and poster Sessions. Future Pharma is a global platform to discuss and learn about research Advances in Digital Pharma & marketing, The Future of Pharma R&D, Industrial Pharmacy and Physical pharmacy, Drug Discovery and Development, Novel Drug Delivery Systems, Pharma and Biotech Financial Outlook.
WHO SHOULD ATTEND?
The conference invites Directors, Group Leaders, Professors, Associate Professors, Lecturers, Research Associates, Scientists, Investigators, business delegates from Leading Universities, Pharmaceutical companies, Formulation Scientists, Medical Devices, Researchers, Health care professionals, across the globe providing a better podium, interconnecting the latest research, technological developments in the arena as well as therapeutic aspects.
The scientific program includes Keynote & Plenary talks, Video Presentations, Poster Presentations and E-Posters. Furthermore, oral communications of (post)doctoral junior scientists will be considered. It is the goal of the organizers to make this meeting an event of scientific excellence, attractive to both industrial and academic scientists in Pharma.
Track 1: Digital Marketing in Pharma Industry
Healthcare industry dramatis personae like a pharma company can use various Digital Marketing platforms for sharing educational content to help their potential and existing clientele, like explaining symptoms, causes, diagnosis, cure etc. for relevant diseases. Digital Marketing is important for Pharma sector. Every pharma companies have not yet fully embraced the digital revolution and changing times, while others have. Well, you should understand that it doesn’t matter to the patients out there, the patients are increasingly expecting, and rightly so, and demanding the pharma and healthcare industry to engage themselves and provide end-to-end services.
The pharma companies that are aligned to changing times, and are using digital mediums, are also the ones reaping the benefits. Great rewards are waiting for those who can cut through all the digital noise and come-up with sustained competitive advantage using digital mediums. The others will also align soon or go out of business.
Track 2: The Future of Pharma R&D
Research & Development is essential in all industries. And, when it arises to the Biopharmaceutical research industry, R&D services not only generates income for the companies involved in the research but it often brings results in lives being set aside, or at least enhancement in patient's lives. The development for lots of companies involves the perfect Pharmaceutical research & development. Research and Development RD is crucial for the growth and future success of research based Pharma companies to maintain their RD organizations efficient pharmaceutical companies started to hedge the potential of open innovation to cut RD costs and to access external knowledge.
Track 3: Pharmaceutical Chemistry
Pharmaceutical chemistry is the study of drugs, and it consists of drug development. This comprises drug discovery, delivery, absorption, metabolism, and more. There are components of biomedical analysis, pharmacology, pharmacokinetics, and pharmacodynamics. Pharmaceutical chemistry effort is frequently done in a lab setting. Pharmaceutical chemistry includes treatments and remedies for disease, analytical techniques, pharmacology, metabolism, quality assurance, and drug chemistry. Pharmaceutical chemistry leads to careers in drug development, biotechnology, pharmaceutical companies, research facilities, and more.
Track 4: Pharmaceutical Analysis
Pharmaceutical Analysis determines the quality of drug products via analytical chemistry. This course will introduce areas such as method validation, handling raw materials and finished products, documentations, inspections that impact the development of pharmaceutical products. Throughout this course, critical cGMPs regulations, FDA guidances and ICH Quality guidelines will be discussed specifically emphasizing procedures to help individuals to maintain a high level of compliance that rounds the laboratory environment. It also reviews several quality systems that support the analytical.
Track 5: Pharmaceutics & Pharmacotherapeutics
Pharmaceutics encompasses a molecular evaluation of drug metabolism and transport processes and the study of genetic, environmental and disease-related factors that regulate or perturb those processes, as well as the fundamental mathematical relationships between enzyme/transporter function, blood concentration-time profiles and the spectrum of pharmacological effects.
Pharmacotherapeutics, The treatment of pathologic conditions through the use of drugs. Pharmacists are specialists in pharmacotherapy and are in charge of guaranteeing the protected, suitable, and prudent utilization of pharmaceutical medications. As pharmacotherapy masters, pharmacists have duty regarding direct patient care, regularly working as an individual from a multidisciplinary group, and going about as the essential wellspring of medication related data for other social insurance experts. A pharmacotherapy expert is a person who is spent significant time in managing and endorsing medicine, and requires broad scholarly information in pharmacotherapy.
Industrial Pharmacists are mainly involved in the research, design, and development and testing of new medicines and treatments, ensuring their safety and quality. This broad research area relates to different functions in pharmaceutical industry and having contact areas with engineering and economics.
A physicochemical principle of pharmacy (physical pharmacy or pharmaceutics) comprises the study of drug formulations and their design, manufacture, and delivery to the body. The definition now extends to the targeting of drugs and delivery systems to specific sites in the body, the fabrication of nanoparticles and the design of delivery devices.
Track 7: Clinical and Hospital Pharmacy
Clinical pharmacy is the discipline of Pharmacy where pharmacists are meant to provide patient care which helps in optimizing the use of drugs and improves health, wellness, and prevents diseases. This session is dealt with topics like basic components of clinical pharmacy practice Prescribing drugs, Reviewing drug use, Administering drugs, Counseling, Documenting professional services, Consulting, Preventing Medication Errors etc.,
The pharmaceutical and healthcare industry is rapidly coming to terms with digital technology. New tech companies are entering the market and existing players have had to up their game, across marketing, sales and operations. If you’re relatively new to Pharma, like me, here’s a summary of just some of the biggest trends.
The pharmaceutical and healthcare industry is rapidly coming to terms with digital technology. Pressure is also mounting on the healthcare industry which has been characterized by rising costs, global competition induced by medical tourism and telemedicine, a growing imbalance of supply and demand as well as increasing customer demands in the recent decade.
Regulatory Affairs contribute essentially to the overall success of drug development, both at early pre-marketing stages and at all times post-marketing. The pharmaceutical industry 2019 deals with an increasing number of interesting drug candidates, all of which necessitate the involvement of the quality assurance in regulatory affairs department. The importance of intellectual property law is well established at all levels-statutory, administrative and judicial. It lays down minimum standards for protection and enforcement in member countries which are required to promote effective and adequate protection of intellectual property rights with a view to reducing distortions and impediments to international trade. The Agreement provides norms and standards in respect of following areas of intellectual properties are Patents, Trademarks, copyrights, Geographical indications, Industrial designs.
Track 10: Pharma and Biotech Financial Outlook
The last few years have been a positive period overall for both the pharmaceutical and biotechnology industries. Most importantly, there has been a renaissance with regard to the increase in the number of new drugs approved and under development for the two segments of the business.
Many of these innovations are driven by new research methods and the growth of new therapeutic options, such as immune-related oncology drugs, personalized medicine, stem cells, and biologics.
The valuations of pharma and biotech companies in the public and M&A markets soared up until August/September of this year in part because of these positive developments. More recently, there has been a setback in public valuations due to the negative publicity about drug pricing.
The overall Pharmaceutical And Biotech Financial Outlook advertise totaled about $123 billion in 2014 and will keep on growing to reach almost $191 billion by 2019, showing a compound yearly development rate (CAGR) of 9.2% amid the conjecture time frame (2014 to 2019).
Track 11: Novel Drug Delivery Systems
The Novel Drug delivery systems are the edifice by which a drug is delivered can have a important effect on its efficacy. Every drugs have an optimum concentration range within which maximum benefit is derived, and concentrations above or below this range can be toxic or produce no Local Drug Delivery Systems benefit at all. On the other pointer, the very slow development in the efficacy of the management of modest diseases, has suggested a growing need for a multidisciplinary approach to the delivery of therapeutics to targets in tissues. From this, new ideas on monitoring the pharmacokinetics, pharmacodynamics, non-specific toxicity, immunogenicity, bio recognition, and efficacy of drugs were generated. These new procedures, often called drug delivery systems (DDS), are based on interdisciplinary approaches that combine polymer science, pharmaceutics, bio conjugate chemistry, and molecular biology.
Track 12: Drug Discovery and Development
Drug discovery is a process in pharmacy which involves the interaction of various disciplines leading to the invention of potent drug entities. The major part of drug design involves the identification of characteristic diagnostic biomarkers such as a protein responsible for the disease or disorder and then developing a drug molecule of therapeutic potency that targets it. The process involves various branches of pharmacology coalesce with biotechnology, bioinformatics, molecular biology, nanotechnology and biochemistry that ultimately leads to the production of molecules of therapeutic value. Despite the advancements in modern technologies and an understanding of the biological systems, the drug discovery process is still a lengthy and expensive task. There are only a few therapeutic drugs that pass the test and enter the market but today's accelerated studies using computational drug design techniques speed up the process of drug discovery.
Track 13: Green and Community Pharmacy
Green Pharmacy is proposed for the need of synthesis from raw materials, production of products, transportation, storage, deliveries, usage, and disposal, are appropriately assessed, anticipated, and managed. Clearly, pharmacists and the practice of the broader pharmaceutical sciences must contribute to achieving a greener pharmacy.
The practice of community pharmacy has extended critical part in giving protected, viable medicine treatment and directing on proper utilize and precautionary measures. Today's people group drug specialists are expecting a more extensive part in advancing health—avoiding malady, enhancing nature of care, and expanding access to mind. Community pharmacists are extending their administrations inside the drug store and past all through the moves of care, working inter professionally to address the issues of the changing medicinal services scene.
Track 14: Big data analytics and Pharma
The future of the Pharmaceutical Industry lies in overcoming barriers to innovation through advances in data analytics. We need to move past the challenge of unstructured data sets and integrating data from multiple sources to begin to work collaboratively with other departments and organizations and create a real world evidence framework for our pharmaceutical development through effective data utilization. The role of data analytics, discussing tangible method for data optimisation, and translating this into real world strategies for companies.
The pharmaceutical industry comprises of companies that are engaged in research, development, manufacture and distribution drugs for human or veterinary use. The primary function of the research-based pharmaceutical corporations is to create value by discovering and producing effective medicines, vaccines and services that improve patients’ well-being, and can be sold in markets at a profit. As well as increasing shareholder value, this contributes significantly to the quality and protection of life and helps make the world a better place. In the past 60 years, innovation and technology have driven huge improvements in global health.
The pharmaceutical industry is undergoing a tremendous deal of change. There are many pharmaceutical companies, who are providing the better products. The Pharma industry is one of the most sought after, and flourished industries. As the pharmaceutical drug manufacturers are one of the reasons for the economic wellbeing of a nation. On the other hand, we can say that the Pharma industry is responsible for the economic development. That is the main reason for both research and development of newer and better products for various kinds of diseases.
Market Analysis of Global Pharmaceutical Industries:
The global $1.12 trillion market in 2022, will rise at a faster clip during 2016-2020, then slow down a bit as major patent expiration take hold. It is expected that the global market declined by 1.0% in 2015, but will grow by 4.8% this year. Prescription sales excluding generics will rise 4.4% this year, and expected to reach $1.006 trillion in 2022. Generics sales will increase from $73 billion in 2015 to $115 billion in 2022, and constitute 10.2% of prescription sales at that point only 0.3 percentage points more than it is now.
The global market for drug discovery technologies and products was worth $38.4 billion in 2011. This figure is projected to reach $41.4 billion in 2012 and $79 billion in 2017, a five-year compound annual growth rate (CAGR) of 13.8%. There is a need to impede serious adverse effects caused by the drugs by enhancing drug targeting through research in pharmacology.
According to the Quintiles IMS Institute predicts that the pharmaceutical market by 2021 will reach nearly USD 1,485 billion, by an increase of USD 350-380 billion from the USD 1,105 billion recorded in 2016. Global brand spending is forecast to increase to USD 815-832 billion in 2021. Global generic spending is expected to increase to USD 495-505 billion by 2021.
The United States share of global spending will increase from USD 461.7 billion in 2016 to USD 645-675 billion in 2021, while the European share of spending will grow from USD 151.8 billion to USD 170-200 billion. Meanwhile, pharma merging countries will spend nearly 315-345 USD billion in 2021 from 242.9 in 2016.